HPV Pilot Action Indonesia

Informations projet

PAHPV-1

N° de convention de subvention: 502455

Projet clôturé

Date de début 15 Avril 2004

Date de fin 14 Août 2005

Financé au titre de

• Specific measures in support of international cooperation: Specific activities covering wider field of research under the Focusing and Integrating Community Research programme 2002-2006.

Coût total € 132 000,00

Contribution de l’UE € 132 000,00

Coordonné par

LEIDEN UNIVERSITY MEDICAL CENTER
Netherlands

Objectif

HPV is the world's most common Sexually Transmitted Disease (STD). Every year 233.000 affected women ideas a result of progressive HPV related disease. Current data suggests that this is due to a lack or diminished immune response against high-risk HPV types.
Individuals who lack strong immunity may benefit from vaccination. In the world wide fight against HPV, a number of research centres are now developing(prophylactic) vaccines. LUMC and its EU-partners are one of the leading consortia. In this pilot action, Lucinda its counterparts in Indonesia (Jakarta and Bali) will run a clinical trial program in a study population of 200women to chart the percentage of individuals at risk for progressive HPV 16.
For this reason the incidence ofHPV16, as well as the immune response to this HPV type will be established. For this purpose the feasibility of simple, low cost DTH-skin test to detect HPV-immune reactivity will be tested. Once the DTH-skin test proves tube useful for detecting protective immune responses against HPV 16 it becomes within reach of other developing countries and will be helpful in the selection of individuals in need of specific vaccination. The test results will be cross-examined in Leiden (NL) with the results of a 'mirror-study' taking place at the sometime in Holland. Furthermore, the results of both studies (Leiden and Indonesia) will be implemented in forthcoming vaccination study against HIV’s this pilot action is to be incorporated in the running STD-education and prevention program of both local health centres, some basic education and training material on HPV will be developed for medical staff and target population.'

Champ scientifique

• medical and health sciences › basic medicine › immunology
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines
• medical and health sciences › clinical medicine › oncology › cervical cancer
• medical and health sciences › health sciences › infectious diseases › DNA viruses

Mots‑clés

• HPV
• epidemiology
• health care system
• infection
• pilot action
• reproductive health
• study
• women

Programme(s)

• FP6-INCO - Specific measures in support of international cooperation: Specific activities covering wider field of research under the Focusing and Integrating Community Research programme 2002-2006.

Thème(s)

• INCO-A.1 - Health and Public Health

Appel à propositions

FP6-2002-INCO-DEV/SSA-1
Voir d’autres projets de cet appel

Régime de financement

SSA - Specific Support Action

Coordinateur

LEIDEN UNIVERSITY MEDICAL CENTER

• Contribution de l’UE: Aucune donnée
• Adresse: Albinusdreef 2 ; LEIDEN ; Pays-Bas
• Coût total: Aucune donnée

Participants (2)

UNIVERSITY OF INDONESIA

Indonésie

• Contribution de l’UE: Aucune donnée
• Adresse: Jalan Salemba 6 ; JAKARTA
• Coût total: Aucune donnée

RUMAH SAKIT SANGLAH

Indonésie

• Contribution de l’UE: Aucune donnée
• Adresse: Jalan Kasehatan, 1 ; DENPASAR
• Coût total: Aucune donnée